EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for PRQR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
March 31, 2026 -0.1486
December 31, 2025 -0.1008
September 30, 2025 -0.1221
June 30, 2025 -0.131
March 31, 2025 -0.1007
December 31, 2024 -0.1028
September 30, 2024 -0.109
June 30, 2024 -0.0355
March 31, 2024 -0.1019
December 31, 2023 -0.0752
September 30, 2023 -0.0767
June 30, 2023 -0.1075
March 31, 2023 -0.1185
December 31, 2022 -0.1752
September 30, 2022 -0.329
June 30, 2022 -0.222
March 31, 2022 -0.227
December 31, 2021 -0.2923
September 30, 2021 -0.2598
June 30, 2021 -0.287
March 31, 2021 -0.2988
December 31, 2020 -0.3141
September 30, 2020 -0.3072
June 30, 2020 -0.0905
March 31, 2020 -0.3544
Date Value
December 31, 2019 -0.4332
September 30, 2019 -0.3468
June 30, 2019 -0.3365
March 31, 2019 -0.4134
December 31, 2018 -0.3806
September 30, 2018 -0.2078
June 30, 2018 -0.2739
March 31, 2018 -0.4104
December 31, 2017 -0.4592
September 30, 2017 -0.4934
June 30, 2017 -0.5176
March 31, 2017 -0.4796
December 31, 2016 -0.4095
September 30, 2016 -0.4799
June 30, 2016 -0.4855
March 31, 2016 -0.4851
December 31, 2015 -0.2846
September 30, 2015 -0.3001
June 30, 2015 -0.4093
March 31, 2015 0.0112
December 31, 2014 -0.1124
September 30, 2014 -0.1855
June 30, 2014 -144.64
March 31, 2014 -0.4111
December 31, 2013 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Pharming Group NV -0.0746
NewAmsterdam Pharma Co. NV -0.398
Kamada Ltd. 0.0716
Syndax Pharmaceuticals, Inc. -0.4835
Opus Genetics, Inc. -0.7542